Cargando…

Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study

Curcumin is a natural compound present in Indian spice turmeric. It has diverse pharmacological action but low oral solubility and bioavailability continue to limit its use as a drug. With the aim of improving the bioavailability of Curcumin (CUR), we evaluated Curcumin-Pyrogallol (CUR-PYR) cocrysta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannava, M. K. Chaitanya, Suresh, Kuthuru, Kumar Bommaka, Manish, Bhavani Konga, Durga, Nangia, Ashwini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874820/ https://www.ncbi.nlm.nih.gov/pubmed/29315234 http://dx.doi.org/10.3390/pharmaceutics10010007

Ejemplares similares

Advances in coamorphous drug delivery systems()
por: Shi, Qin, et al.
Publicado: (2019)

Prediction and Preparation of Coamorphous Phases of a Bislactam
por: Chambers, Luke I., et al.
Publicado: (2022)

Comparison of the physical and thermodynamic stability of amorphous azelnidipine and its coamorphous phase with piperazine
por: Du, Shuang, et al.
Publicado: (2018)

Eutectic Mixture Formation and Relaxation Dynamics of Coamorphous Mixtures of Two Benzodiazepine Drugs
por: Valenti, Sofia, et al.
Publicado: (2023)

Coamorphous Systems of Valsartan: Thermal Analysis Contribution to Evaluate Intermolecular Interactions Effects on the Structural Relaxation
por: Ekawa, Bruno, et al.
Publicado: (2023)

A novel drug–drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide
por: Su, Meiling, et al.
Publicado: (2020)

Advancements in preclinical screening methods for artemisinins during pregnancy
por: Donegan, G, et al.
Publicado: (2010)

Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma
por: Tung, Lai Nar, et al.
Publicado: (2018)

Influence of the pK(a) Value of Cinnamic Acid and P-Hydroxycinnamic Acid on the Solubility of a Lurasidone Hydrochloride-Based Coamorphous System
por: Hu, Yi, et al.
Publicado: (2021)

Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
por: Koga, Yoshikatsu, et al.
Publicado: (2019)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS
por: MEOHAS, WALTER, et al.
Publicado: (2018)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
por: Jung, Joohee
Publicado: (2014)

Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Mechanisms of artemisinin resistance in Plasmodium falciparum malaria
por: Suresh, Niraja, et al.
Publicado: (2018)

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies
por: Hooper, Jody E., et al.
Publicado: (2015)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo
por: Pascoal, Susana, et al.
Publicado: (2020)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Artemisinin
Publicado: (2014)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
por: Dolivo, David, et al.
Publicado: (2021)

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
por: Shankar, Sharmila, et al.
Publicado: (2008)

Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric
por: Prasad, Sahdeo, et al.
Publicado: (2017)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice
por: Thakkar, Arvind, et al.
Publicado: (2016)

Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models
por: Owonikoko, Taofeek K., et al.
Publicado: (2019)

An avian embryo patient-derived xenograft model for preclinical studies of human breast cancers
por: Jarrosson, Loraine, et al.
Publicado: (2021)

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
por: Villafranca-Magdalena, Beatriz, et al.
Publicado: (2022)

Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study
por: Xu, Chang, et al.
Publicado: (2022)

Retraction: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric
Publicado: (2018)

Comparative study of curcumin and curcumin formulated in a solid dispersion: Evaluation of their antigenotoxic effects
por: Mendonça, Leonardo Meneghin, et al.
Publicado: (2015)

Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors
por: Stewart, Elizabeth, et al.
Publicado: (2017)

Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms
por: Zhang, Shuo, et al.
Publicado: (2022)

A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models
por: Pandya, Shaunak K., et al.
Publicado: (2023)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

Circadian rhythm impacts preclinical FDG-PET quantification in the brain, but not in xenograft tumors
por: Krueger, Marcel A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uitvi83jsaddd0s6foprbifnsc